These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Tacrolimus-Induced Diabetic Ketoacidosis After Allogeneic Bone Marrow Transplant.
    Author: Solmaz S, Gökgöz Z, Gereklioğlu Ç, Yeral M, Boğa C, Özdoğu H.
    Journal: Exp Clin Transplant; 2017 Dec; 15(6):702-703. PubMed ID: 26643544.
    Abstract:
    New-onset diabetes mellitus after solid-organ transplant makes for complicated tacrolimus immunosuppression. However, tacrolimus-associated diabetic ketoacidosis has not been reported in bone marrow transplant. We report 24-year-old women, hospitalized with diabetic ketoacidosis, 70 days after undergoing a bone marrow transplant with tacrolimus immunosuppression. Clinicians should be wary about tacrolimus levels and the risk of hyperglycemic states after bone marrow transplant as with other solid-organ transplants.
    [Abstract] [Full Text] [Related] [New Search]